Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2.
Blanca Ramírez M, Lara Ordóñez AJ, Fdez E, Madero-Pérez J, Gonnelli A, Drouyer M, Chartier-Harlin MC, Taymans JM, Bubacco L, Greggio E, Hilfiker S. Blanca Ramírez M, et al. Hum Mol Genet. 2017 Jul 15;26(14):2747-2767. doi: 10.1093/hmg/ddx161. Hum Mol Genet. 2017. PMID: 28453723 Free PMC article.
NADPH oxidases in Parkinson's disease: a systematic review.
Belarbi K, Cuvelier E, Destée A, Gressier B, Chartier-Harlin MC. Belarbi K, et al. Mol Neurodegener. 2017 Nov 13;12(1):84. doi: 10.1186/s13024-017-0225-5. Mol Neurodegener. 2017. PMID: 29132391 Free PMC article. Review.
Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.
Madero-Pérez J, Fdez E, Fernández B, Lara Ordóñez AJ, Blanca Ramírez M, Gómez-Suaga P, Waschbüsch D, Lobbestael E, Baekelandt V, Nairn AC, Ruiz-Martínez J, Aiastui A, López de Munain A, Lis P, Comptdaer T, Taymans JM, Chartier-Harlin MC, Beilina A, Gonnelli A, Cookson MR, Greggio E, Hilfiker S. Madero-Pérez J, et al. Mol Neurodegener. 2018 Jan 23;13(1):3. doi: 10.1186/s13024-018-0235-y. Mol Neurodegener. 2018. PMID: 29357897 Free PMC article.
Transcriptomic signatures of brain regional vulnerability to Parkinson's disease.
Keo A, Mahfouz A, Ingrassia AMT, Meneboo JP, Villenet C, Mutez E, Comptdaer T, Lelieveldt BPF, Figeac M, Chartier-Harlin MC, van de Berg WDJ, van Hilten JJ, Reinders MJT. Keo A, et al. Commun Biol. 2020 Mar 5;3(1):101. doi: 10.1038/s42003-020-0804-9. Commun Biol. 2020. PMID: 32139796 Free PMC article.
Glycosphingolipids and neuroinflammation in Parkinson's disease.
Belarbi K, Cuvelier E, Bonte MA, Desplanque M, Gressier B, Devos D, Chartier-Harlin MC. Belarbi K, et al. Mol Neurodegener. 2020 Oct 17;15(1):59. doi: 10.1186/s13024-020-00408-1. Mol Neurodegener. 2020. PMID: 33069254 Free PMC article. Review.
127 results